196 related articles for article (PubMed ID: 3983831)
1. [Phosphorus and calcium metabolism and its hormonal regulation in chronic kidney failure].
Nikiforova NV; Strunin SE; Ermolenko VM; Mozzhechkov VT; Khomiakova VN
Ter Arkh; 1985; 57(1):103-7. PubMed ID: 3983831
[TBL] [Abstract][Full Text] [Related]
2. [Parathyroid hormone values in patients on chronic dialysis treatment].
Mushmov D; Milkov V; Kiriakov Z; Zakharieva B
Vutr Boles; 1986; 25(3):59-62. PubMed ID: 3765580
[TBL] [Abstract][Full Text] [Related]
3. Plasma calcitonin concentration in patients treated with chronic dialysis: differences between hemodialysis and CAPD.
Martínez ME; Miguel JL; Gómez P; Selgas R; Salinas M; Gentil M; Mateos F; Montero JL; Sánchez Sicilia L
Clin Nephrol; 1983 May; 19(5):250-3. PubMed ID: 6851265
[TBL] [Abstract][Full Text] [Related]
4. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
Chudek J; Piecha G; Kokot F; Wiecek A
J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of PTH/PTHrP receptor in the kidney of patients with renal impairment.
Chen J; Zhang J; Lin S
Chin Med J (Engl); 1998 Jan; 111(1):24-7. PubMed ID: 10322647
[TBL] [Abstract][Full Text] [Related]
6. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
7. Influence of calcium infusion on calcitonin and parathyroid hormone concentrations in normal and hemodialyzed subjects.
Isaac R; Nivez MP; Piamba G; Fillastre JP; Ardaillou R
Clin Nephrol; 1975 Jan; 3(1):14-7. PubMed ID: 1126058
[TBL] [Abstract][Full Text] [Related]
8. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
10. Changes of serum calcium, phosphorus, and parathyroid hormone concentrations and ocular findings among patients undergoing hemodialysis.
Pakdel F; Samimagham H; Shafaroodi A; Sheikhvatan M
Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1142-8. PubMed ID: 22089771
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA
Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
[TBL] [Abstract][Full Text] [Related]
12. [Calcium-phosphate metabolism in chronic polyarthritis].
Siegmeth W; Dudczak R; Zazgornik J
Z Rheumatol; 1982; 41(1):16-8. PubMed ID: 7080689
[TBL] [Abstract][Full Text] [Related]
13. Variability in calcium, phosphorus, and parathyroid hormone in patients on hemodialysis.
Levitt H; Smith KG; Rosner MH
Hemodial Int; 2009 Oct; 13(4):518-25. PubMed ID: 19758299
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
[TBL] [Abstract][Full Text] [Related]
15. Correlation of serum parathormone level with biochemical parameters in chronic renal failure.
Rahman MH; Hossain MM; Sultana S; Jamal CY; Karim MA
Indian Pediatr; 2005 Mar; 42(3):250-4. PubMed ID: 15817973
[TBL] [Abstract][Full Text] [Related]
16. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
17. Pulsatile-secretion of parathyroid hormone in patients with chronic renal failure.
de Francisco AL; Amado JA; Cotorruelo JG; González M; de Castro SS; Canga E; de Bonis E; Ruiz JC; Arias M; Gonzalez-Macías J
Clin Nephrol; 1993 Apr; 39(4):224-8. PubMed ID: 8491053
[TBL] [Abstract][Full Text] [Related]
18. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
Broulík P; Hrubý M
Cas Lek Cesk; 1993 Nov; 132(22):681-3. PubMed ID: 8293434
[TBL] [Abstract][Full Text] [Related]
19. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
20. [The effect of decreasing serum calcium in serum during hemodialysis on PTH levels in children with end stage renal disease].
Sieniawska M; Ziółkowska H; Pańczyk-Tomaszewska M; Weglarska J
Pediatr Pol; 1995 Dec; 70(12):1017-22. PubMed ID: 8649940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
